Twitter

Link your Twitter Account to Market Wire News


When you linking your Twitter Account Market Wire News Trending Stocks news and your Portfolio Stocks News will automatically tweet from your Twitter account.


Be alerted of any news about your stocks and see what other stocks are trending.



home / news releases / ONTX - Onconova Pangea team up to find biomarkers for cancer drug rigosertib


ONTX - Onconova Pangea team up to find biomarkers for cancer drug rigosertib

2023-03-23 08:51:05 ET

  • Onconova Therapeutics ( NASDAQ: ONTX ) and Pangea Biomed are collaborating to identify biomarkers of response to Onconova's cancer drug candidate rigosertib.
  • The research partnership will use Pangea's proprietary algorithmic platform ENLIGHT to identify the biomarkers.
  • "By leveraging Pangea’s AI platform to identify predictive biomarkers of response to rigosertib, we aim to inform a precision medicine approach to selecting additional PLK1-dependent tumors and other indications for its potential evaluation," said Onconova's President and CEO Steven Fruchtman.
  • ONTX +1.11% to $0.72 premarket March 23

For further details see:

Onconova, Pangea team up to find biomarkers for cancer drug rigosertib
Stock Information

Company Name: Onconova Therapeutics Inc.
Stock Symbol: ONTX
Market: NASDAQ
Website: onconova.com

Menu

ONTX ONTX Quote ONTX Short ONTX News ONTX Articles ONTX Message Board
Get ONTX Alerts

News, Short Squeeze, Breakout and More Instantly...